Canopy Rivers (TSX: RIV) (OTC: CNPOF) said that its class A subordinated voting shares will begin trading on the Toronto Stock Exchange under the ticker symbol “RIV” on Sept. 9. On September 24, 2019, Canopy will participate in the TSX market open ceremony. Canopy is focused on investment opportunities in the global cannabis sector. The company identifies cannabis companies that need financial and/or operating support.
Village Farms International (TSX: VFF) (NASDAQ: VFF) announced that its 50%-owned joint venture for cannabis production Pure Sunfarms has received approval from Health Canada to sell dried cannabis products directly to provincial/territorial wholesalers and retailers in accordance with provincial/territorial frameworks in Canada. Pure Sunfarms has supply agreements in place with the Ontario Cannabis Retail Corporation and the British Columbia Liquor Distribution Branch and expects to begin shipping its products in the coming weeks.
The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (US: TGODF) and Caliper Foods unveiled the results of a preliminary human pharmacokinetic study of Caliper CBD, Caliper Foods’ tasteless and odourless water-soluble powder that can be added to almost any food or beverage. TGOD intends to commercialize organic cannabinoid dissolvables in Canada beginning in December 2019 under the TGOD-Infusers line of premium cannabis products.
Medicine Man Technologies (OTCQX: MDCL) has signed a deal to acquire Roots Rx, a cannabis operator with six dispensaries in the ski and mountain towns of Colorado. The company will also acquire Roots Rx’s outdoor cultivation facilities located outside of Aspen.
AMP German Cannabis Group (CSE: XCX) (FSE: C4T) (ISIN: CA00176G1028) has granted incentive stock options to purchase up to 2,123,779 common shares of the company to certain directors, officers, employees and consultants in accordance with its stock option plan, including options to purchase up to 1,175,000 shares to certain directors and officers. Each option vests immediately has an exercise price of $0.50 per share and is exercisable for a period of one year from issuance.
